RIGI and leukemia: On the other hand, although RIG-I has been recognized as a tumor suppressor in several human cancers including ovarian cancer, leukemia and hepatocellular carcinoma [7, 20, 21], a dual role of RIG-I in human head and neck squamous cell carcinoma has been observed [22].